116 related articles for article (PubMed ID: 38359612)
1. PTX3 activates POSTN and promotes the progression of glioblastoma via the MAPK/ERK signalling axis.
Wang Y; Wang B; Cao W; Xu X
Biochem Biophys Res Commun; 2024 Apr; 703():149665. PubMed ID: 38359612
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of the ZNF148/PTX3 axis promotes malignant transformation of dendritic cells in glioma stem-like cells microenvironment.
Cheng S; Liu L; Wang D; Li Y; Li S; Yuan J; Huang S; Xu Z; Jia B; Li Z; Dong J
CNS Neurosci Ther; 2023 Sep; 29(9):2690-2704. PubMed ID: 37063077
[TBL] [Abstract][Full Text] [Related]
4. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
5. Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth.
Zhou W; Ke SQ; Huang Z; Flavahan W; Fang X; Paul J; Wu L; Sloan AE; McLendon RE; Li X; Rich JN; Bao S
Nat Cell Biol; 2015 Feb; 17(2):170-82. PubMed ID: 25580734
[TBL] [Abstract][Full Text] [Related]
6. Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma.
Mikheev AM; Mikheeva SA; Severs LJ; Funk CC; Huang L; McFaline-Figueroa JL; Schwensen J; Trapnell C; Price ND; Wong S; Rostomily RC
Mol Oncol; 2018 Jun; 12(7):1188-1202. PubMed ID: 29754406
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis of cell adhesion molecules in glioblastoma identified prostaglandin F2 receptor inhibitor (PTGFRN) as an essential gene.
Mala U; Baral TK; Somasundaram K
BMC Cancer; 2022 Jun; 22(1):642. PubMed ID: 35690717
[TBL] [Abstract][Full Text] [Related]
8. The promoting effect and mechanism of MAD2L2 on stemness maintenance and malignant progression in glioma.
Liu Z; Wang S; Yu K; Chen K; Zhao L; Zhang J; Dai K; Zhao P
J Transl Med; 2023 Nov; 21(1):863. PubMed ID: 38017538
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of pentraxin-3 in glioblastoma cells correlates with increased invasion and IL8-VEGF signaling axis.
Wesley UV; Sutton I; Clark PA; Cunningham K; Larrain C; Kuo JS; Dempsey RJ
Brain Res; 2022 Feb; 1776():147752. PubMed ID: 34906547
[TBL] [Abstract][Full Text] [Related]
10. PDRG1 promotes the proliferation and migration of GBM cells by the MEK/ERK/CD44 pathway.
Sun J; Xu Y; Liu J; Cui H; Cao H; Ren J
Cancer Sci; 2022 Feb; 113(2):500-516. PubMed ID: 34812552
[TBL] [Abstract][Full Text] [Related]
11. Identification of Periostin as a Potential Biomarker in Gliomas by Database Mining.
Faried A; Hermanto Y; Tjahjono FP; Valentino A; Arifin MZ
World Neurosurg; 2020 Mar; 135():e137-e163. PubMed ID: 31785437
[TBL] [Abstract][Full Text] [Related]
12. UTX inhibition suppresses proliferation and promotes apoptosis in patient-derived glioblastoma stem cells by modulating periostin expression.
Luan Y; Zhang H; Liu Y; Xue J; Wang K; Ma B; Ma K; Lu H; Chen X; Liu Y; Zhang Z
J Cell Physiol; 2024 Apr; 239(4):e31178. PubMed ID: 38214211
[TBL] [Abstract][Full Text] [Related]
13. Circadian regulator CLOCK promotes tumor angiogenesis in glioblastoma.
Pang L; Dunterman M; Xuan W; Gonzalez A; Lin Y; Hsu WH; Khan F; Hagan RS; Muller WA; Heimberger AB; Chen P
Cell Rep; 2023 Feb; 42(2):112127. PubMed ID: 36795563
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
15. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathway.
Peng Y; He X; Chen H; Duan H; Shao B; Yang F; Li H; Yang P; Zeng Y; Zheng J; Li Y; Hu J; Lin L; Teng L
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061180
[TBL] [Abstract][Full Text] [Related]
17. EMP3 as a prognostic biomarker correlates with EMT in GBM.
Li L; Xia S; Zhao Z; Deng L; Wang H; Yang D; Hu Y; Ji J; Huang D; Xin T
BMC Cancer; 2024 Jan; 24(1):89. PubMed ID: 38229014
[TBL] [Abstract][Full Text] [Related]
18. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
[No Abstract] [Full Text] [Related]
19. PTX3 mediates the infiltration, migration, and inflammation-resolving-polarization of macrophages in glioblastoma.
Zhang H; Wang Y; Zhao Y; Liu T; Wang Z; Zhang N; Dai Z; Wu W; Cao H; Feng S; Zhang L; Cheng Q; Liu Z
CNS Neurosci Ther; 2022 Nov; 28(11):1748-1766. PubMed ID: 35855654
[TBL] [Abstract][Full Text] [Related]
20. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2.
Xu L; Duan H; Zou Y; Wang J; Liu H; Wang W; Zhu X; Chen J; Zhu C; Yin Z; Zhao X; Wang Q
Phytomedicine; 2023 Jun; 114():154764. PubMed ID: 36963368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
